KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Exchange Rate Effect: 2012-2024

Historic Exchange Rate Effect for Jazz Pharmaceuticals (JAZZ) over the last 13 years, with Dec 2024 value amounting to -$1.7 million.

  • Jazz Pharmaceuticals' Exchange Rate Effect fell 93.39% to $203,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 million, marking a year-over-year increase of 76.15%. This contributed to the annual value of -$1.7 million for FY2024, which is 247.32% down from last year.
  • Per Jazz Pharmaceuticals' latest filing, its Exchange Rate Effect stood at -$1.7 million for FY2024, which was down 247.32% from $1.1 million recorded in FY2023.
  • Jazz Pharmaceuticals' 5-year Exchange Rate Effect high stood at $1.1 million for FY2023, and its period low was -$6.2 million during FY2022.
  • Its 3-year average for Exchange Rate Effect is -$2.3 million, with a median of -$1.7 million in 2024.
  • Per our database at Business Quant, Jazz Pharmaceuticals' Exchange Rate Effect slumped by 957.49% in 2021 and then spiked by 118.27% in 2023.
  • Over the past 5 years, Jazz Pharmaceuticals' Exchange Rate Effect (Yearly) stood at $374,000 in 2020, then slumped by 957.49% to -$3.2 million in 2021, then plummeted by 94.01% to -$6.2 million in 2022, then skyrocketed by 118.27% to $1.1 million in 2023, then tumbled by 247.32% to -$1.7 million in 2024.